Open AccessIntravenous therapy for the treatment of multiple sclerosis
Author(s) -
Hutchinson Michael,
Nichol Karl,
Nellis Mhairi,
Spicer Jeanette,
Wolfenden Elspeth
Publication year - 2007
Publication title -
future prescriber
Language(s) - English
Resource type - Journals
eISSN - 1931-2261
pISSN - 1468-9871
DOI - 10.1002/fps.4
Subject(s) - multiple sclerosis , medicine , relapsing remitting , disease , axonal degeneration , central nervous system , physical medicine and rehabilitation , pathology , immunology
Abstract Multiple Sclerosis (MS) is a multi‐focal disease of the central nervous system (CNS) that is characterised by inflammation, demyelination and axonal degeneration. In the majority of MS patients, the disease presents with a relapsing remitting course at disease onset. Relapsing remitting MS (RRMS); affects around two thirds of the 85 000 people in the UK with MS. 1 The aims of treatment in RRMS are not only to prevent the rate of relapse, but also to slow down patients' disability progression. Copyright © 2007 Wiley Interface Ltd